Toll-like receptor (TLR) genetic polymorphisms may modify their expression causing inflammatory disorders and influencing both susceptibility and severity of lupus erythematosus. We aim to determine whether TLR-5 and TLR-9 gene polymorphisms are implicated in the susceptibility to systemic lupus erythematosus (SLE) and lupus nephritis (LN) and to evaluate their expressions and distributions in renal LN patients' biopsies. The frequencies of two SNP in the TLR-9 gene and one in the TLR-5 gene was examined in 106 SLE patients (among them 37 LN patients) and in 200 matched controls by polymerase chain reactionrestriction fragment-length polymorphisms (PCR-RFLP) analysis. TLR-9 and TLR-5 expressions were assessed by reverse transcription (RT)-PCR and immunohistochemistry carried on LN renal biopsies compared to healthy renal tissue. A significant genotypic and allelic association was revealed between TLR-9-rs352140 and both SLE and LN (P < 0Á05). The TLR-9 transcript level was significantly higher in LN biopsies compared to control (P < 0Á05). This increase was observed histochemically in the tubulointerstitial compartment. TLR-9 was detectable in LN glomeruli patients but not in normal control glomeruli. No allelic nor genotype association was found with TLR-5-rs5744168 in SLE. but the T allele and the TT genotype were raised significantly in the LN group (P < 0Á05). A significant increase in TLR-5 gene expression in LN biopsies, which contrasted with normal kidneys (P < 0Á05), was confirmed by an intense and diffuse staining for TLR-5 only in LN tubules (P < 0Á05). Our data show that TLR-5 and TLR-9 are susceptible genes to LN and that their expression is dysregulated in LN patients' kidneys, supporting a role of these mediators in the pathogenesis of LN.
Introduction
The pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN), which is the major cause of morbidity in patients with lupus, is highly complex. Genetic predisposition, pro/anti-inflammatory cytokines, autoantibodies and defects in the complement systems all have putative roles in the development of SLE [1] . A variety of immune mechanisms involving innate and adaptive immunity have been implicated in the amplification of the inflammatory response within different organs, such as kidneys. Indeed, renal resident cells activated after injury may also contribute to subsequent destructive processes [2] .
Toll-like receptors (TLRs), pivotal components of the innate immune response, are expressed by the innate system and resident cells of various organs, including kidneys, and may also recognize self-antigens. Consequently, they may be implicated in the initiation of autoreactivity and the amplification of tissue injury in autoimmune diseases [3] . TLRs are key players in the pathogenesis of SLE and lupus-like syndromes [4] . Several studies have demonstrated that polymorphism in TLRs genes can play a crucial role in the development of these diseases [5] [6] [7] .
The TLR-9 gene is mapped to chromosome 3p21.3. The rs351240, located in the second exon, the major coding region of the gene [8] and rs187084, located in the promoter region, where it could influence levels of TLR-9 expression and may affect autoantibody production [9] , are considered among the most-studied single nucleotide polymorphisms (SNPs) in the TLR-9 gene. It is well known that the TLR-9 receptor is activated by hypomethylated cytosine-phosphate-guanosine (CpG) DNA and could initiate and/or modulate autoimmunity by inducing inflammatory cells and production of cytokines or antibodies [10] [11] [12] .
Genetic and functional studies provide a great deal of evidence supporting the independent role of TLR-9 in the pathogenesis of SLE and LN [13] [14] [15] [16] . However, there is still much debate over this issue. Indeed, the deletion of TLR-9 in lupus-prone models does not lead to disease amelioration, as predicted, but to disease exacerbation, suggesting a protective role of TLR-9 in lupus in mice [17] [18] [19] [20] .
Previous studies have shown that the chromosomic region 1q41 is a susceptibility locus to SLE in different populations [21, 22] . The TLR-5 gene, a bacterial flagellin innate immune receptor [23] , is located at this region. It has a common stop codon polymorphism in the ligandbinding domain, making it unable to mediate flagellin signalling. This TLR-5 polymorphism has been found to be associated with resistance to SLE [24] and susceptibility to an increased risk for urinary tract infection in adult women [25] . However, TLR-5 role in LN remains largely unknown.
The aim of this study was to determine the association of TLR-9 and TLR-5 genes polymorphism with susceptibility to SLE and their possible implication in renal involvement by investigating their local renal expression in LN biopsies.
Materials and methods

Subjects
A case-control study was performed on a total of 106 SLE patients recruited from the Internal Medicine and Nephrology Department of the Hedi Chaker University Hospital. All patients fulfilled the revised criteria of the American College of Rheumatology for SLE [26] . Thirty-seven LN patients were confirmed by renal biopsy and classified according to the International Society of Nephrology/Renal Pathology Society classification of LN (ISN/RPS) 2003 revised classification system [27] . Two hundred unrelated healthy subjects served as controls. Five ml blood was collected from the above-mentioned individuals and the DNA was extracted by the phenol-chloroform method.
For all patients, the results of immunological tests [antinuclear antibodies (ANA), anti-DNA antibodies, anti-RNP, anti-Sm, etc.] used for correlation tests were collected from patients' sera and performed in the clinical laboratory of immunology at Habib Bourguiba Hospital for daily routine [Euroline ANA Profile 3plus DFS 70, immunoglobulin (Ig)G; Euroimmun, L€ ubeck, Germany].
The study was approved by the ethical committee of the Habib Bourguiba University Hospital (protocol number: 4/ 12). Written consent was obtained from the participants before enrolment into the study.
Detection of SNPs in TLR genes
All individuals were genotyped for rs187084 and rs352140 in TLR-9 and rs5744168 in TLR-5. Genotyping was based on the detection of SNPs by polymerase chain reaction followed by restriction fragment-length polymorphisms (PCR-RFLP), as shown in Table 1 .
Immunohistochemistry
Thirty renal biopsy specimens from our 37 LN patients (in seven cases, tissues were not available) were collected from the Anatomopathology Department of the Habib Bourguiba Hospital, compared to six renal tissues obtained from the normal part of nephrectomized kidneys (because of renal carcinoma) and five cadaver kidneys (autopsy) from subjects without renal disease. All biopsies were taken for immnohistochemical staining of TLR-9 and TLR-5. In brief, paraffin-embedded tissue sections, 3-4 lm thick, were mounted on positively charged slides and heated at 608C for 30 min, then deparaffinized and rehydrated through a series of alcohols before staining. After antigen retrieval, endogenous peroxidase was blocked with 3% hydrogen peroxide for 5 min. Sections were washed three times with cold 0Á01 M phosphate-buffered saline (PBS) after blocking with 0Á4% buffered casein solution; slides were incubated for 1 h with anti-TLR-9 and 30 min with anti-TLR-5 antibodies (HPA004731 and HPA015573, respectively; Sigma, St Louis, MO, USA) at 1 : 50 dilution. 
Scoring of kidney biopsies
Stained biopsy sections were evaluated by an anatomopathologist. For every section, TLR-9 and TLR-5 expression score was assigned by giving a score ranging from 0 to 12 resulting in the product: intensity score 3 diffusion score. The intensity score was 0 for negative, 1 for weakly positive, 2 for moderately positive and 3 for strongly positive.
The diffusion score was the ratio of the stained tubuli or glomeruli to total observed tubuli or glomeruli of each specimen: 0 for 0%, 1 for 0-25%, 2 for 25-50%, 3 for 50-75% and 4 for > 75%.
Total RNA isolation and reverse transcriptionpolymerase chain reaction (RT-PCR)
Total RNA was isolated from fresh renal biopsies (five renal biopsies from LN patients obtained from nephrology department of the Hedi Chaker University Hospital and four renal control biopsies from normal patients undergoing total nephrectomy because of renal carcinoma obtained from the urology department of Habib Bourguiba University Hospital) conserved in RNAlater V R (Ambion, Inc., Austin, TX, USA) at 2808C, using an RNA extraction kit (RNeasy V R Mini Kit; Qiagen, Valencia, CA, USA), according to the manufacturer's instructions.
RNA was reverse-transcribed to cDNA using a highcapacity cDNA synthesis kit (Applied Biosystems, Vilnius, Lithuania). Gene expression was analysed by quantitative RT-PCR (QPCR) in a StepOnePlus Real Time PCR system (Applied Biosystems, Foster City, CA, USA). qPCR was performed using duplicates with predesigned TaqMan probe and primer sets from Applied Biosystems [TLR-5 Hs01920773_s1, TLR9 Hs00370913_s1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Hs02758991_g1]. Quantification was performed using the standard curve method with GAPDH as endogenous control for normalization for gene expression. The logarithms of mean expression levels were used in Mann-Whitney U-tests of qPCR data.
Statistical analysis
Data were analysed statistically using the Shesis program [28] and SPSS software version 20. The direct gene counting method was applied to determine the frequencies of the genotypes and alleles. These frequencies were tested for Hardy-Weinberg equilibrium by v 2 test. Observed genotype-phenotype association analyses were performed using Pearson's v 2 and Student's t-tests in patient samples. The Mann-Whitney U-test was used to analyse the differences in TLR-9 and TLR-5 expression in renal tissues between healthy controls and patients. Statistical significances were calculated using the Kruskal-Wallis test when comparing LN classes. The t-test was used for the association studies. The significance level of P < 0Á05 and odds ratios (OR) with 95% confidence intervals (CI) was chosen for all sets.
Results
Our study cohort was composed of 106 SLE patients and 200 healthy subjects. Patients' clinical data are summarized in Table 2 . The 30 LN patients had received neither corticoids (> 10 mg) nor immunosuppressive drugs during the last 3 months.
Association between investigated SNPs and occurrence of SLE and LN
The allelic and genotypic distribution showed that only the C allele of the TLR-9-rs3532140 and its homozygote genotype conferred a significant risk of developing SLE in our population (C versus T; P 5 0Á013, OR 5 1Á532, 95% CI 5 1.09$2, 14; CC versus CT 1 TT; P 5 0Á005, OR 511Á3, 95% CI 5 1Á47$504). None of the two other investigated SNPs (TLR-9-rs187084 and TLR-5-rs5744168) showed any association with SLE (Table 3 ).
Investigating the polymorphisms described above in the LN patient group, the same associations of TLR-9 rs352140 were conserved and even more pronounced (CC versus CT 1 TT; P 5 8Á41e
25
, OR 5 4Á1; 95% CI 5 1Á96$8Á57). Interestingly, a new allelic and genotypic association was found with the TLR-5 gene SNP studied. Indeed, the T allele appears to be a risk allele to develop LN (P 5 0Á03, OR 5 3Á764, 95% CI 5 1Á035$13Á692), while the TT genotype was detected only in LN patients (P 5 0Á04) ( Table 3 ).
In SLE and LN patients the LD analysis, measured by D' , revealed that two of the TLR-9 investigated polymorphisms were in weak linkage (D' 5 0Á63 and 0Á66, respectively).
We calculated the significance of association of the different haplotypes generated by the three SNPs studied with the susceptibility to SLE and LN. None of the four haplotypes was associated significantly with SLE. However, the frequency of the CTC haplotype was lower in LN cases than in controls (23Á6 versus 39%, P 5 0Á03, OR 5 0Á529, 95% CI 5 0Á298$0Á941), which could argue in favour of its protective role (Table 4) .
Association between investigated SNPs and serological and clinical parameters in SLE and LN patients
We further analysed the contribution of these polymorphisms to the phenotypical heterogeneity of SLE and their influence on serological and clinical parameters of this disease.
Within SLE patients, the TLR-9-rs352140 TT genotype was associated negatively with the presence of anticardiolipin (ACL)m antibodies (P 5 0Á014), while a positive association appeared between the CC genotype and anti-b2GP1g antibodies (P 5 0Á028) ( Table 5) .
Within the LN patient group, correlation analysis showed that the TLR-9-rs352140 CT genotype contributed to a malar rash (P 5 0Á04) and correlated with the presence of anti-Scl70 antibodies (P 5 0Á018), while the TT genotype was associated with the presence of anti-SSA antibodies (P 5 0Á04) (Table 5) .
Conversely, the TLR-9-rs187084 CC genotype appeared to be associated with low levels of both C3 and CH50 (P 5 0Á04, P 5 0Á036, respectively), while the TT genotype was associated with pleurisy (P 5 0Á028). Within LN patients, anti-Sm antibodies showed a positive association with the TLR-9-rs187084 CT genotype and a negative association with the TT genotype (Table 5) .
Regarding TLR-5, the rs5744168 CC genotype was associated with Raynaud syndrome and anaemia in both SLE and LN patients, while the ACLg antibody presence was associated exclusively with the CC genotype in SLE patients (Table 6 ).
TLR-9 and TLR-5 expression in renal biopsies of LN patients
Immunohistochemical examination. This examination revealed that the LN patient renal biopsies displayed an intense and diffuse TLR-9 and TLR-5 staining in tubuli. This tubular expression was significantly higher compared to normal controls (P 5 0Á029, P 5 0Á006, respectively) (Fig. 1) . TLR-9 glomerular expression was weakly detected in LN renal specimens and was absent in normal tissues, while TLR-5 expression in glomeruli was rarely detected in both LN patients and controls.
Gene expression analysis. qPCR results showed a significant increase of TLR-9 and TLR-5 mRNA levels in LN patients compared with those in healthy patients (P < 0Á05) (Fig. 2) .
TLR-9 and TLR-5 renal expression in LN classes
Upon intersubset analysis, a significant difference was observed in both TLR-9 and TLR-5 expression in tubular cells, between different histological classes (P 5 0Á034, P 5 0Á023 respectively). It was noted that TLR-9 expression was highest in class V patients compared to classes II and III, IV, III 1 IV, III 1 V patient subsets (Fig. 3) . Conversely, TLR-5 tubular expression reached its highest score in III, IV, III 1 IV, III 1 V and stabilized in class V (Fig. 4) . Concerning glomerular class expression, variance was observed mainly in TLR-9, which differs significantly between classes II and III, IV, III 1 IV, III 1 V and class V. However, TLR-5 glomerular expression did not vary significantly between classes.
Discussion
Genetic studies examined the contribution of TLRs polymorphisms to the manifestation of SLE, and a variety of functional studies have suggested a role for these receptors in the aethiopathology of LN [29] [30] [31] . Studies that use genetic and functional investigations to clarify this contribution are rare. In the present work, we placed emphasis on a possible role of TLR-9 and TLR-5 in SLE, and more specifically in the LN subtype, by genotype-phenotype correlation study and a transcriptomic/proteomic analysis.
Our results revealed no significant difference between the allelic and genotypic distribution of TLR-9-rs187084 polymorphism between SLE patients and controls, which indicates the absence of association of this polymorphism to both SLE and LN. A similar observation was reported in different Asian populations; namely, Chinese [32] , South Korean [33] and Japanese [11] , and recently among North Indians [34] . Upon stratification by ethnicity, a metaanalysis showed no association between TLR-9-rs187084 and SLE in the Asian population, while it indicated an association between the two alleles of this polymorphism and SLE in the overall population (P 5 0Á038) [35] . Regarding the second TLR-9 variant, rs351240, results showed that the C allele and the CC genotype predispose a significant risk of developing SLE with renal clinical complications. Conversely, a recent metaanalysis showed no association between the two alleles of the rs352140 polymorphism and the risk of developing SLE in Caucasian, Asian and African populations [35] . However, in agreement with our findings, two Chinese studies reported an association between rs351240 and lupus, but with the T allele in the dominant model [36, 37] . These conflicting results of an association between TLR-9 gene polymorphisms and SLE could be caused by the different genetic background of each population.
Toll-like receptor in lupus nephritis
Several publications have examined correlations between the TLR polymorphisms and SLE clinical and serological markers, but the conclusions have been conflicting. In our report, despite the lack of a genetic association between TLR-9-rs187084 and susceptibility to disease, the negative correlation of SLE patients with the CC genotype with low levels of CH50 and C3 and those with the TT genotype associated with pleurisy, the association of LN patients with TT and CT genotypes with the presence of anti-Sm antibodies suggests that the T variant is associated with several immunological disorders of SLE. Thus, to confirm the role of the TLR-9-rs187084 polymorphism in SLE, this study should be replicated in a larger independent cohort.
The analysis of TLR-9-rs352140 genotypic frequencies according to different single criteria of SLE showed some associations with serological parameters, but did not indicate any significant association with clinical features; indeed, the susceptible genotype CC is associated positively with anti-b2GP1. The fact that this genotype is associated significantly with both SLE occurrence and nephritis lends further support to its implication in SLE pathogenesis.
The TLR-5-rs5744168 polymorphism, involved in the transition at base pair 1174 from cytosine-to-thymidine, generates a stop codon that may affect TLR-5 function [38] . In our study, and despite the TLR-5 gene location at the 1q41-1q42 region, which is known to be in association with SLE [21, 22, 39] , we did not find any significant association between TLR-5-rs5744168 and SLE. This result agrees with two other case-control studies, showing that this polymorphism does not influence susceptibility to SLE [40, 41] .
However, in a familial study using the TDT test, Hwan et al. [24] reported that this polymorphism confers protection from developing SLE. This discrepancy may be due to the difference in methodology between the TDT test and case-control study, as reported by Demicri et al. [40] , or to the small cohort size. Anti-SSA antibodies 22Á9% n.s. 22Á9% n.s. 14Á3% (P 5 0Á049) Anti-Scl70 antibodies 0% n.s. 8Á6% (P 5 0Á018) 0 n.s. Malar rash 12Á1% n.s. 21% (P 5 0Á047) 3% n.s. rs 187084 SLE patients CH50 levels 13% (P 5 0Á036) 58Á5% n.s. 28Á5% n.s. C3 levels 10% (P 5 0Á04) 58Á1% n.s. 31% (P 5 0Á014) Pleurisy 1Á5% n.s. 4Á5% n.s.
7Á6% (P 5 0Á028) LN patients
Anti-Sm antibodies 0% n.s. 36Á1% (P 5 0Á013) 8Á3% (P 5 0Á05) % 5 positivity for two parameters; n.s. 5 non-significant; SLE 5 systemic lupus erythematosus; LN 5 lupus nephritis. P, v 2 test. Surprisingly, we found a significant association between the TLR-5-rs 5744168 polymorphism and LN. In fact, the TLR-5 TT and TC genotypes exhibited a significantly increased risk of developing renal disease; the TT genotype was present exclusively in LN patients. Our genotypic frequencies are in good agreement with those observed by Sanchez et al. [41] , who reported a significant increase frequency in the CC genotype among SLE patients without nephritis (P 5 0Á03).
Toll-like receptor in lupus nephritis
The relationship between the TLR-5-rs5744168 polymorphism and LN was confirmed in a murine genetic study, which showed that the Sle1d locus, corresponding to human chromosome 1q41-1q42, is involved in the development of nephritis [42] .
With regard to TLR-9, TLR-5-rs5744168 was associated with some clinical and serological features. Interestingly, the TLR-5-rs5744168 CC genotype was significantly more frequent in patients seronegative for ACL antibodies, while TC and TT genotypes were more frequent in ACL antibodypositive patients. Taking into account the relationship between ACL antibodies and infections and the functional consequence of the T allele in rs5744168, which results in a truncated receptor [38, 43] , our findings may lend support to a functional problem in TLR-5 contributing to an infectious trigger in ACL seropositive SLE patients. Further analyses are therefore needed to confirm this finding. These genetic results and correlations between the TLR polymorphisms and SLE clinical and serological markers suggest a link between TLR-9 and TLR-5 and LN. Thus, evaluating the renal expression of these two TLRs in LN patient biopsies was necessary to assess their implication in the physiopathological disease process.
TLR-9 immunohistochemical staining revealed that this receptor is expressed diffusely in both glomerular and tubular cells in LN biopsies, while in control biopsies it was expressed only by tubuli. Our data agree with other investigations: two studies confirmed that TLR-9, expressed highly in LN patient biopsies, displayed intense signaling mainly in tubules and was undetectable in control tissues, and that glomerular TLR-9 expression was observed only in the LN kidneys but not in normal renal samples [44] [45] [46] [47] . The common characteristic shared by these studies is the increase of TLR-9 expression in LN kidneys, which is also confirmed by findings of qPCR experimentation, even though the expression site diverges from one population to another. Three studies [45] [46] [47] confirmed glomerular expression in LN biopsies, as reported in our Tunisian patients. Conversely, in the Benigni et al. [44] study, it was undetectable. Regarding the control biopsies, there are discrepancies concerning the presence of a tubular expression. Indeed, in our Tunisian and Greek populations [46] , control tubular cells express only TLR-9. Perhaps these differences imply the genetic background of each ethnicity. Further analyses are required to understand and specify these variances more clearly.
Interestingly, we report a significant difference in TLR-9 expression between LN classes; TLR-9 tubular expression differs significantly between class V patients compared to class II patients and patients within classes III, IV, III 1 IV, III 1 V. In fact, class V patients displayed the highest TLR-9 tubular expression. Herein, we report that TLR-9 is expressed not only in renal tubules and interstitial tissue, but also in the glomeruli of lupus patients with proliferative and membranous nephritis. This finding is sustained by the results of Conti et al. [47] , that revealed when comparing TLR expression among different histological classes, a significantly higher tubulointerstitial and glomerular TLR-9 was found in class IV versus classes II and III. Taken together, these results support a strong implication of TLR-9 in the pathogenesis process of LN.
The contribution of TLR-5 in this chronic renal inflammation remains unknown, and investigations concerning the implication in glomerulonephritis are scanty. Immunohistochemical staining and aPCR experiments provide, for the first time, a relationship between TLR-5 expression levels and LN severity. We showed an intense and diffuse renal tubuli expression of TLR-5 in LN biopsies compared to controls, which exhibited a weak expression. Moreover, upon intersubset analysis, we noted that TLR-5 tubular expression varied and reached its highest record in classes III, IV, III 1 IV and III 1 V and then stabilized at class V. We speculate that the extent of tubulointerstitial involvement seems to predict the renal outcome more efficiently than glomerular inflammation severity.
The initiation and perpetuation of the inflammatory kidney responses in LN may result, in part, from an exaggerated host defence reaction of the glomeruli to endo-and exogenous bacterial flora which itself changes during kidney injury. We hypothesize that the composition of bacterial flora might also have a TLR-5-dependent effect on LN progression. Results presented herein suggest a putative role of locus in TLR-5 and TLR-9 genes and confirm an extensive over-expression of these two receptors in LN kidneys, which suggests that these innate modulators exert an influence in the progression of LN. Further, their increased transcript level on the same LN biopsy prompted us to investigate the nature of the relationship between these two receptors and determine whether they act synergistically. Taking into account that they follow the same signalling pathway, their activation may have a cumulative effect on the amplification of the inflammatory loop. Further functional studies may be useful to confirm that targeting the signalling pathway instead of using antagonists in the treatment of LN could be promising. 
